Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07847476
NA
Flubendazole Added to Standard Concurrent Chemoradiotherapy With Temozolomide in Patients With High-Grade Glioma
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
This study To evalute the efficacy and safety of adding flubendazole to standard concurrent chemoradiotherapy with temozolomide in patients with high grade glioma and also to evaluate DFS,OS for those patients in clinical oncology department , Assiut university Hospital .
Official title: A Phase II Study of Adding Flubendazole to Standard Concurrent Chemoradiotherapy With Temozolomide in Patients With High-Grade Glioma
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
122
Start Date
2026-10-01
Completion Date
2028-12-01
Last Updated
2026-09-29
Healthy Volunteers
No
Conditions
Interventions
DRUG
Flubendazole
Flubendazole 100 mg twice daily for 3 day in the week for 6 weeks